Skip to main content
Premium Trial:

Request an Annual Quote

Nanosphere Respiratory Panel Categorized as Moderate Complexity

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere today said that the US Food and Drug Administration has notified the firm that its Verigene SP respiratory virus panel has been categorized as "moderate complexity" under the Clinical Laboratory Improvement Amendments of 1988.

The test runs on the firm's Verigene SP molecular diagnostics system, the newer version of its flagship Verigene platform.

The moderate complexity designation will allow the test to be run in more settings than under its previous designation of "high complexity" on the older system. Nanosphere noted that the respiratory virus panel for the Verigene SP is the first of its tests to receive the moderate complexity designation.

The Northbrook, Ill.-based firm said that it intends to seek the moderate complexity designation for all of its assays.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.